AAAAAA

   
Results: 1-15 |
Results: 15
Sumatriptan, 5-MT1D receptors and obsessive-compulsive disorder
Authors: Koran, LM Pallanti, S Quercioli, L
Citation: Lm. Koran et al., Sumatriptan, 5-MT1D receptors and obsessive-compulsive disorder, EUR NEUROPS, 11(2), 2001, pp. 169-172
5-HT1D function and repetitive behaviors
Authors: Hollander, E Pallanti, S
Citation: E. Hollander et S. Pallanti, 5-HT1D function and repetitive behaviors, AM J PSYCHI, 158(6), 2001, pp. 972-973
Abnormal visual event-related potentials in obsessive-compulsive disorder without panic disorder or depression comorbidity
Authors: Di Russo, F Zaccara, G Ragazzoni, A Pallanti, S
Citation: F. Di Russo et al., Abnormal visual event-related potentials in obsessive-compulsive disorder without panic disorder or depression comorbidity, J PSYCH RES, 34(1), 2000, pp. 75-82
Subjective experience and subjective response to neuroleptics in schizophrenia
Authors: Rossi, A Arduini, L Stratta, P Pallanti, S
Citation: A. Rossi et al., Subjective experience and subjective response to neuroleptics in schizophrenia, COMP PSYCHI, 41(6), 2000, pp. 446-449
Use of ECT in Italy - Dr. Pallanti replies
Authors: Pallanti, S
Citation: S. Pallanti, Use of ECT in Italy - Dr. Pallanti replies, AM J PSYCHI, 157(5), 2000, pp. 840-840
Citalopram for treatment-resistant obsessive-compulsive disorder
Authors: Pallanti, S Quercioli, L Paiva, RS Koran, LM
Citation: S. Pallanti et al., Citalopram for treatment-resistant obsessive-compulsive disorder, EUR PSYCHIA, 14(2), 1999, pp. 101-106
Effects of clozapine on awareness of illness and cognition in schizophrenia
Authors: Pallanti, S Quercioli, L Pazzagli, A
Citation: S. Pallanti et al., Effects of clozapine on awareness of illness and cognition in schizophrenia, PSYCHIAT R, 86(3), 1999, pp. 239-249
The emergence of social phobia during clozapine treatment and its responseto fluoxetine augmentation
Authors: Pallanti, S Quercioli, L Rossi, A Pazzagli, A
Citation: S. Pallanti et al., The emergence of social phobia during clozapine treatment and its responseto fluoxetine augmentation, J CLIN PSY, 60(12), 1999, pp. 819-823
Basic symptoms and P300 abnormalities in young schizophrenic patients
Authors: Pallanti, S Quercioli, L Pazzagli, A
Citation: S. Pallanti et al., Basic symptoms and P300 abnormalities in young schizophrenic patients, COMP PSYCHI, 40(5), 1999, pp. 363-371
Axis I comorbidity in bipolar disorder with psychotic features
Authors: Pini, S Dell'osso, L Mastrocinque, C Marcacci, G Papasogli, A Vignoli, S Pallanti, S Cassano, G
Citation: S. Pini et al., Axis I comorbidity in bipolar disorder with psychotic features, BR J PSYCHI, 175, 1999, pp. 467-471
Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder
Authors: Pallanti, S Quercioli, L Pazzagli, A Rossi, A Dell'Osso, L Pini, S Cassano, GB
Citation: S. Pallanti et al., Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder, AM J PSYCHI, 156(7), 1999, pp. 1094-1096
Obsessive-compulsive disorder: Theory, research, and treatment
Authors: Pallanti, S
Citation: S. Pallanti, Obsessive-compulsive disorder: Theory, research, and treatment, AM J PSYCHI, 156(7), 1999, pp. 1108-1109
Citalopram and sexual side effects of selective serotonin reuptake inhibitors
Authors: Pallanti, S Koran, LM
Citation: S. Pallanti et Lm. Koran, Citalopram and sexual side effects of selective serotonin reuptake inhibitors, AM J PSYCHI, 156(5), 1999, pp. 796-796
Ugo Cerletti 1877-1963
Authors: Pallanti, S
Citation: S. Pallanti, Ugo Cerletti 1877-1963, AM J PSYCHI, 156(4), 1999, pp. 630-630
Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder
Authors: Marazziti, D Pallanti, S
Citation: D. Marazziti et S. Pallanti, Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder, AM J PSYCHI, 156(11), 1999, pp. 1834-1835
Risultati: 1-15 |